Veterinary Antimicrobial Susceptibility Testing Market Size (2024 - 2029)

Veterinary Antimicrobial Susceptibility Testing Market Analysis

The Veterinary Antimicrobial Susceptibility Testing Market size is estimated at USD 1 billion in 2024, and is expected to reach USD 1.40 billion by 2029, growing at a CAGR of 5.90% during the forecast period (2024-2029).

Rising antimicrobial resistance (AMR) had been ringing alarm bells across the world long before COVID-19. Globally, there was an alarming trend of multi-drug resistance as the pandemic grappled. As per the article published during Covid under the title “Antimicrobial susceptibility patterns of respiratory gram-negative bacterial isolates from COVID-19 patients in Switzerland,” the development of bacterial superinfections in ventilated COVID-19 patients was impacted by high levels of AMR, which in some situations necessitate continued modification of antibiotic therapy. The result of drug-resistant infections made illnesses more prolonged. Death rates became more severe and common. COVID-19 significantly impacted the market studied.

AMR poses a global problem that jeopardizes the effectiveness of treatments for bacterial infections and hampers essential medical advancements in veterinary medicine, such as complex surgeries and chemotherapy. According to the World Health Organization (WHO), if not effectively managed, AMR could lead to an estimated 10 million annual deaths by 2050, a number comparable to other severe illnesses such as cancer.

The rise of AMR has emphasized the pivotal role of clinical microbiology laboratories in promoting the responsible use of antibiotics and guiding appropriate treatment choices. Susceptibility testing is crucial in providing guidance for antimicrobial treatment, as antimicrobial resistance is one of the top public health challenges globally. Insufficient use or inadequate utilization of microbiological culture and antimicrobial susceptibility testing (AST), along with excessive reliance on empirical antibiotic treatment, can contribute to the worsening of AMR in veterinary healthcare. To address these challenges, a closer collaboration between diagnostic laboratories and healthcare providers is necessary to effectively implement antimicrobial stewardship practices, thereby accelerating the demand and leading the growth of the veterinary antimicrobial susceptibility testing market.

However, challenges such as high cost associated with testing and limited awareness and training gaps could impede innovation and rapid expansion of the veterinary antimicrobial susceptibility testing market. Despite acknowledging the importance of antimicrobial treatment, there remains a significant need to standardize the training of clinical microbiologists and the diagnostic procedures they use. This need is especially pronounced in the field of veterinary clinical microbiology, where additional challenges exist in fulfilling professional roles.

Improving the output of veterinary microbiology laboratories requires addressing specific issues, such as the harmonization of methodologies used for antimicrobial susceptibility testing (AST), the establishment of guidelines for interpreting and reporting AST results for animal pathogens, guidelines for detecting antimicrobial resistance mechanisms in animal isolates, standardization of diagnostic procedures for animal clinical specimens, and the increased training of veterinary clinical microbiology specialists.

Veterinary Antimicrobial Susceptibility Testing Industry Segmentation

Veterinary antimicrobial susceptibility testing involves the assessment of microbial susceptibility to antimicrobial agents in animals. It employs laboratory techniques to determine the effectiveness of antimicrobials against specific pathogens, aiding veterinarians in making informed decisions for effective treatment.

The veterinary antimicrobial susceptibility testing market is segmented by product type into disks and plates, culture media, automated testing systems, and other product types. By animal type, the market is segmented into companion animals [dog, cat, and others] and livestock [cattle, pigs, and others]). By end user, the market is segmented into veterinary reference labs, veterinary research institutes, and other end users. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The report offers market sizes and forecasts in terms of value (USD) for the above segments.